Peptide-Based Treatment: A Promising Cancer Therapy
作者： Yu-Feng Xiao , Meng-Meng Jie , Bo-Sheng Li , Chang-Jiang Hu , Rui Xie
DOI: 10.1155/2015/761820
关键词:
摘要: Many new therapies are currently being used to treat cancer. Among these methods, chemotherapy based on peptides has been of great interest due the unique advantages peptides, such as a low molecular weight, ability specifically target tumor cells, and toxicity in normal tissues. In treating cancer, peptide-based can be mainly divided into three types, peptide-alone therapy, peptide vaccines, peptide-conjugated nanomaterials. Peptide-alone therapy may enhance immune system's response kill cells. Peptide-based vaccines have advanced cancers improve patients' overall survival. Additionally, combination with nanomaterials expands therapeutic cancer by enhancing drug delivery sensitivity. this review, we focus advances application recent years, including diagnosis, treatment, prognosis.
hindawi.com
core.ac.uk参考文章(131)
Aarif Ahsan, Susmita G. Ramanand, Ingrid L. Bergin, Lilli Zhao, Christopher E. Whitehead, Alnawaz Rehemtulla, Dipankar Ray, William B. Pratt, Theodore S. Lawrence, Mukesh K. Nyati, Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts Neoplasia. ,vol. 16, pp. 105- 114 ,(2014) , 10.1593/NEO.14182
H. L. Pearce, Anna Maria Storniolo, S. R B Allerheiligen, Preclinical, pharmacologic, and phase I studies of gemcitabine. Seminars in Oncology. ,vol. 24, ,(1997)
Liquan Gao, Ilaria Bellantuono, Annika Elsässer, Stephen B. Marley, Myrtle Y. Gordon, John M. Goldman, Hans J. Stauss, Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood. ,vol. 95, pp. 2198- 2203 ,(2000) , 10.1182/BLOOD.V95.7.2198
Anna K Nowak, Bruce W S Robinson, Richard A Lake, Gemcitabine Exerts a Selective Effect on the Humoral Immune Response Implications for Combination Chemo-immunotherapy Cancer Research. ,vol. 62, pp. 2353- 2358 ,(2002)
Robert E. Schoen, The case for population-based screening for colorectal cancer Nature Reviews Cancer. ,vol. 2, pp. 65- 70 ,(2002) , 10.1038/NRC705
Jaimy MS Saif, Jayakumar Vadakekolathu, Shraddha S Rane, Danielle McDonald, Murrium Ahmad, Morgan Mathieu, A Graham Pockley, Lindy Durrant, Rachael Metheringham, Robert C Rees, Stephanie EB McArdle, None, Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice. European Journal of Immunology. ,vol. 44, pp. 994- 1004 ,(2014) , 10.1002/EJI.201343863
Martin Trepel, Renata Pasqualini, Wadih Arap, Chapter 4 Screening Phage‐Display Peptide Libraries for Vascular Targeted Peptides Angiogenesis: In Vivo Systems, Part B. ,vol. 445, pp. 83- 106 ,(2008) , 10.1016/S0076-6879(08)03004-8
Francesco M. Marincola, Elizabeth M. Jaffee, Daniel J. Hicklin, Soldano Ferrone, Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Advances in Immunology. ,vol. 74, pp. 181- 273 ,(2000) , 10.1016/S0065-2776(08)60911-6
Danila Valmori, Francine Jotereau, Jean François Fonteneau, Nadine Gervois, Jean Charles Cerottini, Jean Charles Cerottini, Concepción Marañón Lizana, Victor Jongeneel, Pedro Romero, Pedro Romero, Danielle Liénard, Danielle Liénard, Donata Rimoldi, Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues Journal of Immunology. ,vol. 160, pp. 1750- 1758 ,(1998)
Jiankun Qiang, Xin Tong, Nan Jiang, Ruihua Xue, Fangfang Bu, Rong Liu, Decreased RGS6 expression is associated with poor prognosis in pancreatic cancer patients. International Journal of Clinical and Experimental Pathology. ,vol. 7, pp. 4120- 4127 ,(2014)